Abstract
A catalytic continuous flow approach towards pharmaceutically relevant oxazolidinones has been developed using epoxy alcohols and CO2 as reagents, taking advantage of a stable, scalable and metal- and halide-free protocol.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
